How will the acquisition impact Home Depotâs earnings per share and operating margins over the next 12â18 months?
Fundamental impact
The GMS purchase adds a proven specialtyâdistribution platform that should generate roughlyâŻ$130â$150âŻmillion of incremental preâtax profit in 2025â26âŻ(ââŻ$1.0â$1.2âŻbillion of revenue at a 13â14% EBIT margin). Because the deal was executed through SRSâŻââŻa cashâgenerating subsidiary ââŻthe financing cost is modest (mainly netâdebt assumed). Consequently, HomeâŻDepotâs diluted earnings per share (EPS) is expected to be upâtrendâweighted by 3â5âŻcents over the next 12â18âŻmonths, on top of the FYâ24 FYâ25 guidance already in place. The operatingâmargin profile will be mixed in the near term: the GMS profit mix sits at a slightly lower margin than HomeâŻDepotâs coreâstore business, which will modestly drag the consolidated margin down (ââŻ30âŻbps) for the first halfâyear after close. By Q4â26 the upsideâside synergies (crossâselling, consolidated logistics, and SG&A rationalisation) should lift the combined operating margin to ~2â3âŻpercentageâpoints above the preâacquisition level.
Market / technical overlay
The transaction was announced with the typical âaccretionâ narrative; the stock has already reâpriced the deal premium, holding just shy of the 200âday moving average (~âŻ$330) and testing the $310â$320 support zone on lowerâthanâaverage volume. A breakout above $330 with volume above the 20âday average could confirm the marketâs belief that the marginâimprovement timeline will accelerate, opening the door for a shortâterm pullâback to the $310â315 range (a buying opportunity for traders with a 6âmonth horizon). Conversely, any indication that integration costs rise or that GMS margins deteriorate could pressure the stock back toward $295â$300, where the 50âday moving average and recent lowâbounce bounce sit.
Actionable view
- Longâterm holders: The acquisition is an EPSâpositive, marginâenhancing catalyst. Maintain a core position; the incremental 3â5âŻcents EPS accretion and ~2âŻ% margin lift justify a modest upside over the next 12â18âŻmonths.
- Shortâterm traders: Look for a buy on dip at $310â$315 (near the 20âday SMA) with a stop just below $300. Target the $340â$350 range as the market digests the Q4â26 margin synergies.
Overall, the deal should be a modest, positive earnings driver with an initially small margin compression that reverses into a clear operatingâmargin boost by the second half of 2026.